Assertio Holdings | DEPO - Cash And Equivalent


Assertio Holdings reported $38.5M in Cash and Equivalent for its fiscal quarter ending in September of 2025.





Cash And Equivalent Change Date
ANI Pharmaceuticals USD 311.18M 25.59M Mar/2026
Assertio Holdings USD 38.5M 8.59M Sep/2025
Aurora Cannabis CAD 56.36M 39.33M Dec/2025
Cara Therapeutics USD 20.73M 684K Dec/2025
Daiichi Sankyo JPY 542.16B 97.68B Sep/2025
Ironwood Pharmaceuticals USD 220.47M 5.01M Mar/2026
J&J USD 21.69B 1.98B Mar/2026
Knight Therapeutics CAD 76.45M 5.43M Dec/2025
Merck USD 5.33B 9.24B Mar/2026
Nektar Therapeutics USD 15.12M 25.92M Dec/2025
Omeros USD 1.9M 2.36M Jun/2025
Pfizer USD 1.7B 561M Mar/2026
Teva Pharmaceutical Industries USD 3.56B 1.35B Dec/2025